Abstract
There is strong need to develop the current stratified practice of CVD management into a better personalized cardiovascular medicine, within a broad framework of global patient care. Clinical information obtained from history and physical examination, functional and imaging studies, biochemical biomarkers, genetic/epigenetic data, and pathophysiological insights into disease-driving processes need to be integrated into a new taxonomy of CVDs to allow personalized disease management. This has the potential for major health benefits for the population suffering from cardiovascular diseases.
| Original language | English |
|---|---|
| Pages (from-to) | 3250-7 |
| Number of pages | 8 |
| Journal | European Heart Journal |
| Volume | 35 |
| Issue number | 46 |
| DOIs | |
| Publication status | Published - 7 Dec 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biological Markers
- Cardiovascular Diseases
- Clinical Trials as Topic
- Diagnostic Imaging
- Diffusion of Innovation
- Evidence-Based Medicine
- Genomics
- Humans
- Individualized Medicine
- Needs Assessment
- Patient-Centered Care
- Risk Assessment
Fingerprint
Dive into the research topics of 'The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver